Glenmark gets USFDA nod to market generic version of Otezla tablets

The company has received final approval from the US Food & Drug Administration (USFDA) for Apremilast tablets in strength of 10 mg, 20 mg and 30 mg, the Mumbai-based drug maker said in a statement.

Related Keywords

United States ,Mumbai ,Maharashtra ,India ,American , ,Us Food Drug Administration ,Glenmark Pharmaceuticals On ,Drug Administration ,Business ,Companies ,Glenmark ,Usfda ,